(R)-styrene oxide

Overview

DrugBank ID
DB04499
Type
Small Molecule
US Approved
NO
Other Approved
NO
Clinical Trials
Phase 0
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Identification

Generic Name
(R)-styrene oxide
DrugBank Accession Number
DB04499
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 120.1485
Monoisotopic: 120.057514878
Chemical Formula
C8H8O
Synonyms
  • (R)-(+)-styrene oxide
  • (R)-(epoxyethyl)benzene
  • R-phenyloxirane
  • R-styrene oxide

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UHalohydrin dehalogenaseNot AvailableAgrobacterium tumefaciens
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Not Available
Direct Parent
Benzene and substituted derivatives
Alternative Parents
Oxacyclic compounds / Epoxides / Dialkyl ethers / Hydrocarbon derivatives
Substituents
Aromatic heteromonocyclic compound / Dialkyl ether / Ether / Hydrocarbon derivative / Monocyclic benzene moiety / Organic oxygen compound / Organoheterocyclic compound / Organooxygen compound / Oxacycle / Oxirane
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
styrene oxide (CHEBI:45389)
Affected organisms
Not Available

Chemical Identifiers

UNII
0HB27D5MRW
CAS number
20780-53-4
InChI Key
AWMVMTVKBNGEAK-QMMMGPOBSA-N
InChI
InChI=1S/C8H8O/c1-2-4-7(5-3-1)8-6-9-8/h1-5,8H,6H2/t8-/m0/s1
IUPAC Name
(2R)-2-phenyloxirane
SMILES
C1O[C@@H]1C1=CC=CC=C1

References

General References
Not Available
PubChem Compound
114705
PubChem Substance
46507332
ChemSpider
102702
ChEBI
45389
ChEMBL
CHEMBL1235743
ZINC
ZINC000000901251
PDBe Ligand
RSO
PDB Entries
1pwz

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.26 mg/mLALOGPS
logP1.72ALOGPS
logP1.74Chemaxon
logS-2ALOGPS
pKa (Strongest Basic)-4.2Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area12.53 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity35.33 m3·mol-1Chemaxon
Polarizability12.94 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.9735
Caco-2 permeable+0.7899
P-glycoprotein substrateNon-substrate0.8055
P-glycoprotein inhibitor INon-inhibitor0.9671
P-glycoprotein inhibitor IINon-inhibitor0.9578
Renal organic cation transporterNon-inhibitor0.8499
CYP450 2C9 substrateNon-substrate0.8176
CYP450 2D6 substrateNon-substrate0.9055
CYP450 3A4 substrateNon-substrate0.7672
CYP450 1A2 substrateInhibitor0.7046
CYP450 2C9 inhibitorNon-inhibitor0.7229
CYP450 2D6 inhibitorNon-inhibitor0.9463
CYP450 2C19 inhibitorInhibitor0.5337
CYP450 3A4 inhibitorNon-inhibitor0.9872
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.5403
Ames testAMES toxic0.9106
CarcinogenicityNon-carcinogens0.652
BiodegradationReady biodegradable0.7562
Rat acute toxicity1.8104 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9553
hERG inhibition (predictor II)Non-inhibitor0.955
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-9300000000-576e978c3f21382a16a1
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0fb9-9300000000-ea17de55bf8eceb018cf
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0gb9-0900000000-f244924f48b70f41d815
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-6900000000-8c2c752cac4bf6f7915e
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0uxr-0900000000-e353020f23432e6ddd84
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-9100000000-eddc7e7f432b2d181103
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9300000000-6a5c2530d5c02021dfef
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-122.32792
predicted
DeepCCS 1.0 (2019)
[M+H]+125.32377
predicted
DeepCCS 1.0 (2019)
[M+Na]+134.39381
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Agrobacterium tumefaciens
Pharmacological action
Unknown
General Function
Not Available
Specific Function
Not Available
Gene Name
hheC
Uniprot ID
Q93D82
Uniprot Name
Halohydrin dehalogenase
Molecular Weight
27951.525 Da

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52